https://www.stocktitan.net/news/AEMD/aethlon-medical-reports-second-quarter-fiscal-2027-results-and-vu1acjb5pr1u.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/AEMD/aethlon-medical-reports-second-quarter-fiscal-2027-results-and-vu1acjb5pr1u.html?utm_source=stocktitan-bluesky&utm_medium=social
EIC Pathfinder funding for the POLARIS project! Led by the AEMD Group, it aims to develop new #graphene-brain implants combining precise brain signal recording and targeted stimulation to advance neurological research.
🔍 https://f.mtr.cool/0huzgjcqwr
#Neurotechnology
EIC Pathfinder funding for the POLARIS project! Led by the AEMD Group, it aims to develop new #graphene-brain implants combining precise brain signal recording and targeted stimulation to advance neurological research.
🔍 https://f.mtr.cool/0huzgjcqwr
#Neurotechnology
LAROSA STEVEN P (Chief Medical Officer) reported special transactions (Non-P/S).
LAROSA STEVEN P (Chief Medical Officer) reported special transactions (Non-P/S).
Rossetti Angela () reported special transactions (Non-P/S).
Rossetti Angela () reported special transactions (Non-P/S).
Shah Chetan () reported special transactions (Non-P/S).
Shah Chetan () reported special transactions (Non-P/S).
Gikakis Nicolas () reported special transactions (Non-P/S).
Gikakis Nicolas () reported special transactions (Non-P/S).
BROENNIMAN EDWARD G () reported special transactions (Non-P/S).
BROENNIMAN EDWARD G () reported special transactions (Non-P/S).
FRAKES JAMES B (CFO/CEO) reported special transactions (Non-P/S).
FRAKES JAMES B (CFO/CEO) reported special transactions (Non-P/S).
Jane Street: 0 → 5% (about $210K)
13G: a passive investor, not seeking to influence the company
SEC Schedule 13G · filed Oct 13
#Investing #Stocks
Visit for more info: www.elixstocks.com
Educational only. Not investment advice.
Jane Street: 0 → 5% (about $210K)
13G: a passive investor, not seeking to influence the company
SEC Schedule 13G · filed Oct 13
#Investing #Stocks
Visit for more info: www.elixstocks.com
Educational only. Not investment advice.
No valid summary extracted.
No valid summary extracted.
No valid summary extracted.
No valid summary extracted.
prismmarketview.com/eczema-aware...
prismmarketview.com/eczema-aware...
Proposal No. 7: The Company’s stockholders did not approve a proposed amendment to the Company's Articles of Incorporation to authorize 20,000,000 shares of preferred stock, par value $0.001 per share, and authorize the Board of Directors to establish one or more series thereof and to fix...
Proposal No. 7: The Company’s stockholders did not approve a proposed amendment to the Company's Articles of Incorporation to authorize 20,000,000 shares of preferred stock, par value $0.001 per share, and authorize the Board of Directors to establish one or more series thereof and to fix...
(d) Exhibits . Exhibit No. Description 10.1 Aethlon Medical, Inc. 2020 Equity Incentive Plan, as amended to date, Form of Restricted Stock Grant, Form of Option Grant and Agreement. 104 Cover Page Interactive Data File (embedded within the inline XBRL Document) 4 SIGNATURES Pursuant to th...
(d) Exhibits . Exhibit No. Description 10.1 Aethlon Medical, Inc. 2020 Equity Incentive Plan, as amended to date, Form of Restricted Stock Grant, Form of Option Grant and Agreement. 104 Cover Page Interactive Data File (embedded within the inline XBRL Document) 4 SIGNATURES Pursuant to th...
#$AEMD stock alert record: Aethlon Medical moved from a reported 2.44 entry to a verified 14.00 intraday high. Review timing, sources, and risks.
stockmarketloop.com/aemd-stock-1...
#$AEMD stock alert record: Aethlon Medical moved from a reported 2.44 entry to a verified 14.00 intraday high. Review timing, sources, and risks.
stockmarketloop.com/aemd-stock-1...
Supportive points: Merger with North Immunology to advance novel bispecific antibody targeting IL-13 and IL-18.
https://market-scanner.net/tickers/AEMD.US
#ai #trading
Supportive points: Merger with North Immunology to advance novel bispecific antibody targeting IL-13 and IL-18.
https://market-scanner.net/tickers/AEMD.US
#ai #trading
finance.yahoo.com/community/po...
The latest Retail Trader Spotlight breakdown reviews a documented #$AEMD alert with a reported $2.44 entry and a separate market-data high of $14.00.
finance.yahoo.com/community/po...
The latest Retail Trader Spotlight breakdown reviews a documented #$AEMD alert with a reported $2.44 entry and a separate market-data high of $14.00.
Previous winners: $VRA $IPEX $MYSZ
Catch the next winner: https://DDAmanda.com
Previous winners: $VRA $IPEX $MYSZ
Catch the next winner: https://DDAmanda.com